Saurabh Saha

Chief Executive Officer and Director

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

CNTA

CEO, Board Member

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Centessa Pharmaceuticals plc (CNTA)	M.D., Ph.D. Former Chief Executive Officer	$683,884	$411,000	—	$10,755,360	—	$27,000	$11,877,244
2024	Centessa Pharmaceuticals plc (CNTA)	M.D., Ph.D. Chief Executive Officer	$669,982	$544,005	$1,155,042	$3,180,291	—	$13,800	$5,563,120
2023	Centessa Pharmaceuticals plc (CNTA)	M.D., Ph.D. Chief Executive Officer	$652,050	$376,559	$813,890	$850,175	—	$13,200	$2,705,874
2022	Centessa Pharmaceuticals plc (CNTA)	M.D., Ph.D. Chief Executive Officer	$621,000	$324,472	$3,877,500	$4,777,058	—	$12,200	$9,612,230
2021	Centessa Pharmaceuticals plc (CNTA)	M.D., Ph.D. Chief Executive Officer	$572,581	$414,630	—	$15,081,376	—	—	$16,068,587
2020	Centessa Pharmaceuticals plc (CNTA)	M.D., Ph.D. Chief Executive Officer	—	—	—	—	—	—	—

Earnings-call appearances and filed executive appointments or departures, newest first.